Arrowhead Pharmaceuticals
ARWR
#2176
Rank
$8.49 B
Marketcap
$61.44
Share price
-4.98%
Change (1 day)
160.23%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): -$75.08 Million USD

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are $0.57 Billion USD. In 2024 the company made an earning of -$0.61 Billion USD a decrease over its 2023 earnings that were of -$0.29 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$75.08 Million-87.49%
2024 -$0.61 Billion112.45%
2023 -$0.29 Billion87.79%
2022 -$0.16 Billion-20.1%
2021 -$0.19 Billion67.59%
2020 -$0.12 Billion-347.53%
2019 $45.39 M-245.59%
2018 -$31.18 Million-13.17%
2017 -$35.91 Million-52.28%
2016 -$75.26 Million-16.57%
2015 -$90.2 Million30.32%
2014 -$69.21 Million171.62%
2013 -$25.49 Million16.56%
2012 -$21.87 Million107.53%
2011 -$10.54 Million
2008 -$37.11 Million-8.07%
2007 -$40.37 Million70.37%
2006 -$23.69 Million122.51%
2005 -$10.65 Million147.41%
2004 -$4.31 Million2002.28%
2003 -$0.21 Million-85.61%
2002 -$1.43 Million1371.97%
2001 -$0.1 Million-13.45%
2000 -$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alnylam Pharmaceuticals
ALNY
$0.13 B-273.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion 56.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$66.79 M-188.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-$0.11 Billion 43.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-43,253.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-$3.15 Billion 4,089.31%๐Ÿ‡บ๐Ÿ‡ธ USA